ChildStats.gov—Forum on Child and Family Statistics
faces of children
Home  |  About the Forum  |  Publications  |  Data Sources  |  Help
Search
HC3 Childhood immunization: Percentage of children ages 19–35 months vaccinated for selected diseases by poverty status,a and raceb and Hispanic originc, 1996–2006

excel icon HC3 Excel Table

  Total Below Poverty At or above poverty
Characteristic 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006
Total
Combined Series (4:3:1:3:3:1)d — — — — — — 65.5 72.5 76.0 76.1 76.9 — — — — — — 61.6 69.7 72.6 73.9 73.4 — — — — — — 66.3 73.6 77.4 77.2 78.3
Combined Series (4:3:1:3:3)e 67.7 68.5 72.7 73.2 72.8 73.7 74.8 79.4 80.9 80.8 80.5 61.4 63.6 67.8 68.3 67.2 68.0 69.3 75.0 76.8 77.4 76.3 69.9 70.7 74.8 75.3 74.9 75.2 76.2 81.3 82.8 82.5 82.2
Combined series (4:3:1:3)f 76.4 76.2 79.2 78.4 76.2 77.2 77.5 81.3 82.5 82.4 82.1 68.9 70.7 74.1 73.3 70.5 71.5 71.8 76.2 78.0 79.2 77.8 79.2 78.9 81.5 80.7 78.3 78.9 79.0 83.3 84.6 84.1 83.9
Combined series (4:3:1)g 78.4 77.9 80.6 79.9 77.6 78.6 78.5 82.2 83.5 83.1 83.1 71.6 72.4 76.2 75.2 72.3 73.2 72.8 77.2 78.9 79.6 79.0 80.8 80.3 82.7 82.0 79.3 80.1 80.0 84.1 85.5 84.8 84.8
DTP (4 doses or more)h 81.1 81.5 83.9 83.3 81.7 82.1 81.6 84.8 85.5 85.7 85.2 73.9 75.8 79.5 78.5 76.2 76.5 75.4 79.7 81.2 81.8 80.8 83.6 83.9 86.1 85.4 83.5 83.6 83.5 86.8 87.4 87.4 86.9
Polio (3 doses or more)i 91.0 90.7 90.8 89.6 89.5 89.4 90.2 91.6 91.6 91.7 92.8 87.7 89.3 89.9 87.4 86.9 87.4 88.3 89.1 89.8 89.7 91.9 92.0 91.5 91.7 90.5 89.9 90.1 90.6 92.5 92.2 92.4 93.1
MMR (1 dose or more)j 90.6 90.4 92.0 91.5 90.5 91.4 91.6 93.0 93.0 91.5 92.3 87.2 85.7 90.1 90.0 88.9 89.1 90.2 92.0 91.3 89.3 90.9 91.9 92.0 93.1 92.4 90.9 91.9 91.9 93.4 93.5 92.1 93.0
Hib (3 doses or more)k 91.4 92.5 93.4 93.5 93.4 93.0 93.1 93.9 93.5 93.9 93.4 86.9 89.5 91.1 90.8 90.1 89.6 90.1 91.1 91.7 91.9 91.1 93.1 94.1 94.5 95.0 94.5 94.2 93.9 95.0 94.4 94.6 94.2
Hepatitis B (3 doses or more)l 81.8 83.6 87.0 88.1 90.3 88.9 89.9 92.4 92.4 92.9 93.3 78.0 80.7 85.3 86.5 87.3 86.5 87.7 91.1 91.4 91.4 92.7 83.2 84.9 87.7 89.0 91.4 89.5 90.3 93.2 92.8 93.5 93.5
Varicella (1 dose or more)m 12.2 25.8 43.2 57.5 67.8 76.3 80.6 84.8 87.5 87.9 89.2 5.4 16.9 40.5 55.4 63.5 74.0 78.9 84.4 86.4 87.3 88.3 15.3 29.1 44.1 58.2 69.2 77.1 80.9 85.0 87.5 87.7 90.0
PCV (3 doses or more)n — — — — — — 40.8 68.1 73.2 82.8 86.9 — — — — — — 33.2 62.2 69.0 78.3 84.1 — — — — — — 43.4 70.6 75.3 84.4 88.0
White, non-Hispanic
Combined Series (4:3:1:3:3:1)d — — — — — — 66.2 73.9 77.2 76.0 77.8 — — — — — — 58.9 69.2 71.6 70.3 69.0 — — — — — — 67.0 74.5 78.0 77.2 78.9
Combined Series (4:3:1:3:3)e 68.9 70.4 75.6 75.6 76.0 75.2 77.7 82.5 83.3 82.1 82.2 59.3 64.3 71.8 70.9 69.8 67.7 70.0 77.4 76.5 76.3 74.1 70.5 71.4 76.1 76.3 77.0 76.2 78.4 83.1 84.3 83.4 83.1
Combined series (4:3:1:3)f 78.5 78.7 82.2 81.0 79.4 78.8 80.2 84.3 85.1 83.6 83.9 68.0 71.8 77.3 75.7 72.9 71.3 71.8 78.9 77.6 77.5 75.2 80.4 80.2 83.1 81.8 80.4 78.9 81.0 85.0 86.2 84.8 84.9
Combined series (4:3:1)g 80.1 80.2 83.3 82.0 80.3 79.9 81.2 85.0 85.7 84.0 84.7 70.3 73.3 78.5 77.1 73.6 71.9 73.0 79.9 78.0 77.7 76.7 81.9 81.7 84.1 82.8 81.3 81.0 82.0 85.6 86.9 85.3 85.7
DTP (4 doses or more)h 82.7 83.9 86.6 85.5 84.3 83.5 84.4 87.5 87.7 87.1 86.6 72.4 76.0 81.5 81.0 78.0 74.6 74.6 82.0 80.5 81.4 78.0 84.7 85.4 87.6 86.3 85.2 84.6 85.5 88.1 88.8 88.1 87.6
Polio (3 doses or more)i 91.9 91.5 92.2 90.3 90.6 90.1 91.2 93.0 92.1 91.4 93.3 88.2 90.3 90.9 87.7 87.7 87.4 88.0 90.8 88.3 87.4 90.1 92.5 92.0 92.6 90.8 90.9 90.5 91.5 93.3 92.6 92.3 93.6
MMR (1 dose or more)j 91.4 91.4 93.1 92.4 91.5 91.7 92.6 93.2 93.5 91.4 92.8 85.1 84.3 90.4 90.3 88.4 87.2 90.4 89.7 89.9 86.7 87.7 92.5 92.7 93.7 92.8 91.6 92.2 92.9 93.5 94.1 92.1 93.5
Hib (3 doses or more)k 92.8 93.9 95.0 94.8 94.7 94.2 94.1 95.1 94.7 94.2 94.1 87.4 89.9 92.2 92.5 92.2 89.2 88.4 90.9 92.1 89.4 87.9 93.7 94.7 95.5 95.2 95.1 94.7 94.7 95.7 95.1 95.1 94.8
Hepatitis B (3 doses or more)l 82.1 84.6 88.3 88.9 91.4 89.6 90.9 93.2 93.0 93.1 93.8 76.4 80.4 87.2 87.8 87.8 86.0 85.9 90.6 91.6 90.2 91.7 83.3 84.9 88.3 89.0 91.9 89.9 91.5 93.6 93.1 93.6 94.0
Varicella (1 dose or more)m 14.5 27.5 41.9 56.0 66.4 74.7 79.4 83.8 86.5 86.1 88.7 6.4 16.5 37.5 50.7 58.4 67.1 75.0 79.5 83.7 82.3 83.2 16.3 29.3 42.8 56.6 67.8 75.7 80.2 84.6 86.9 86.6 89.4
PCV (3 doses or more)n — — — — — — 43.5 70.9 75.3 83.2 87.2 — — — — — — 31.3 58.8 65.7 76.4 79.5 — — — — — — 45.6 72.7 77.1 84.3 88.4
Black, non-Hispanic
Combined Series (4:3:1:3:3:1)d — — — — — — 61.7 68.4 70.9 76.3 73.8 — — — — — — 59.3 63.7 68.1 73.5 71.7 — — — — — — 62.1 71.9 74.6 80.1 76.8
Combined Series (4:3:1:3:3)e 66.8 65.6 66.6 69.4 68.2 67.1 67.7 73.0 74.5 79.3 76.7 61.3 63.8 66.9 66.9 66.8 65.0 65.9 68.9 72.0 75.8 74.0 71.9 69.5 67.5 72.9 69.5 68.6 68.3 76.8 78.2 83.0 80.4
Combined series (4:3:1:3)f 74.2 72.8 72.9 73.8 70.6 71.4 70.7 75.2 76.0 80.5 78.4 69.3 71.1 71.9 72.4 68.5 68.7 68.4 70.2 73.8 76.8 75.8 79.1 76.5 74.1 76.7 72.2 74.1 71.7 78.8 79.6 83.8 81.9
Combined series (4:3:1)g 76.6 74.0 74.3 75.1 71.5 72.8 71.6 76.7 77.8 81.4 78.9 72.5 72.0 73.6 73.8 69.6 70.7 69.3 71.6 76.0 77.8 76.5 80.9 77.7 75.7 77.9 73.2 75.1 72.6 80.2 81.2 84.2 82.4
DTP (4 doses or more)h 79.0 77.2 77.3 79.0 76.4 76.3 75.8 79.9 79.5 84.0 81.2 74.3 75.9 77.0 77.9 74.5 74.2 73.5 74.6 77.8 79.7 78.8 83.3 80.0 78.8 82.5 78.0 78.1 77.3 83.9 82.8 87.5 84.8
Polio (3 doses or more)i 90.1 89.1 87.8 87.0 86.8 84.9 87.4 89.2 90.4 91.0 90.4 86.8 89.2 88.3 86.2 85.1 84.3 87.0 86.0 89.5 89.0 90.4 92.6 90.5 86.9 88.4 87.1 86.1 87.1 91.4 91.1 92.6 91.4
MMR (1 dose or more)j 89.7 89.0 88.8 89.8 87.9 89.1 90.3 92.1 90.7 91.9 90.9 88.3 87.0 88.8 90.2 88.4 88.3 89.8 91.3 90.1 91.3 90.8 90.8 91.3 89.8 90.9 87.3 89.9 90.2 92.5 91.3 92.8 91.6
Hib (3 doses or more)k 89.4 91.4 90.1 91.8 92.8 89.5 91.6 92.4 90.9 92.9 91.0 85.9 91.0 90.3 90.7 91.9 87.1 88.3 90.0 89.6 91.6 89.9 92.8 93.7 89.6 94.1 93.4 91.3 93.9 94.6 92.3 94.8 93.4
Hepatitis B (3 doses or more)l 81.9 82.0 83.7 86.5 89.2 84.9 88.0 91.6 90.8 92.7 91.5 77.8 81.9 86.1 85.6 88.6 84.7 88.6 91.5 89.2 92.7 91.6 85.0 84.3 82.8 89.9 90.2 85.3 87.7 92.2 92.1 94.1 92.5
Varicella (1 dose or more)m 8.6 20.8 42.4 57.6 67.3 75.3 82.7 85.4 86.3 90.6 89.1 — 15.7 40.1 57.1 60.2 71.3 79.7 83.7 85.2 91.0 89.2 12.9 27.1 44.4 60.4 72.1 77.1 83.6 86.1 87.4 90.8 89.8
PCV (3 doses or more)n — — — — — — 33.9 62.3 68.2 79.6 82.9 — — — — — — 30.2 61.3 66.5 76.8 82.2 — — — — — — 37.5 63.7 69.6 82.2 84.5
Hispanicc
Combined Series (4:3:1:3:3:1)d — — — — — — 66.0 71.3 75.9 75.6 77.0 — — — — — — 66.0 73.1 75.0 75.6 76.4 — — — — — — 65.5 70.3 77.5 74.8 78.3
Combined Series (4:3:1:3:3)e 63.7 65.7 68.7 69.6 68.5 74.1 72.7 77.0 79.7 78.8 79.7 62.4 62.2 65.1 68.0 66.2 69.8 71.8 76.8 78.9 78.3 78.3 64.1 69.8 73.3 72.9 70.3 75.7 72.9 78.3 81.7 79.1 81.6
Combined series (4:3:1:3)f 71.1 72.6 75.3 74.9 72.7 77.0 75.5 78.7 81.2 81.2 81.3 68.2 69.6 72.9 73.3 69.9 73.1 74.8 77.6 79.8 80.9 80.1 72.7 76.7 79.1 78.4 74.1 78.8 75.6 80.6 83.5 81.9 83.2
Combined series (4:3:1)g 74.1 74.5 77.2 77.3 74.8 79.0 76.5 79.3 82.2 81.8 82.0 70.9 71.1 75.5 75.6 73.1 75.5 75.6 78.7 80.3 81.0 80.9 74.6 77.4 80.2 80.1 75.1 79.7 76.6 80.9 84.3 82.7 83.9
DTP (4 doses or more)h 77.2 77.7 80.5 80.2 78.6 82.5 79.2 81.9 84.1 83.6 84.5 74.0 74.9 79.0 77.9 76.1 79.1 77.9 81.1 82.5 82.5 82.7 77.5 80.6 83.2 82.4 79.9 83.1 79.7 83.5 86.0 84.9 86.3
Polio (3 doses or more)i 89.4 89.7 88.9 89.4 87.9 90.7 90.4 90.1 91.2 92.3 93.3 88.0 88.4 90.1 88.8 87.7 89.6 89.3 89.3 90.1 91.5 93.0 89.8 90.2 90.3 89.9 86.9 91.1 90.7 91.5 92.2 92.3 93.4
MMR (1 dose or more)j 88.2 88.4 91.0 90.2 90.0 92.1 90.5 92.7 93.2 91.1 92.0 87.4 85.2 90.4 89.9 90.0 90.5 90.8 93.4 92.1 89.5 92.8 89.0 89.5 92.3 91.3 90.0 92.7 89.0 93.4 93.5 91.4 91.9
Hib (3 doses or more)k 88.5 90.0 91.7 92.0 91.1 92.5 92.4 93.1 92.6 94.2 93.9 87.1 89.0 91.8 90.7 87.7 91.3 93.1 91.7 91.8 93.6 93.5 90.3 92.3 93.5 95.1 93.3 94.4 92.2 95.1 94.4 93.9 93.9
Hepatitis B (3 doses or more)l 80.8 81.2 85.7 87.3 88.2 89.8 89.5 91.2 91.9 92.7 93.6 79.9 78.8 83.1 86.5 86.7 88.1 89.0 90.7 91.3 91.5 93.2 81.1 84.4 88.3 88.9 89.7 91.0 88.9 92.8 92.9 92.8 93.9
Varicella (1 dose or more)m 7.6 22.4 46.9 60.5 70.2 80.3 81.8 85.7 89.1 89.2 89.6 6.3 17.6 44.0 58.6 69.9 80.7 82.4 87.8 88.1 88.4 90.5 11.2 25.3 48.8 61.7 69.8 81.8 80.6 84.7 89.4 88.8 90.5
PCV (3 doses or more)n — — — — — — 37.4 65.5 70.4 83.5 88.9 — — — — — — 35.1 65.1 71.2 80.0 87.7 — — — — — — 37.6 67.4 71.4 86.0 89.8
— Not available.
aBased on family income and household size using US Bureau of Census poverty thresholds for the year of data collection.
bFrom 1996 to 2000, the 1977 OMB Standards for Data on Race and Ethnicity were used. Beginning in 2002, the 1997 OMB Standards for Data on Race and Ethnicity were used.
cPersons of Hispanic origin may be of any race.
dThe 4:3:1:3:3:1 series consists of 4 doses (or more) of diphtheria, tetanus toxoids and pertussis (DTP) vaccines, diphtheria and tetanus toxoids (DT), or diphtheria, tetanus toxoids and any acellular pertussis (DTaP) vaccines; 3 doses (or more) of poliovirus vaccines; 1 dose (or more) of any measles-containing vaccine; 3 doses (or more) of Haemophilus influenzae type b (Hib) vaccines; 3 doses (or more) of hepatitis B vaccines; and 1 dose (or more) of varicella vaccine. The collection of coverage rate estimates for this series began in 2002.
eThe 4:3:1:3:3 series consists of 4 doses (or more) of diphtheria, tetanus toxoids and pertussis (DTP) vaccines, diphtheria and tetanus toxoids (DT), or diphtheria, tetanus toxoids and any acellular pertussis (DTaP) vaccines; 3 doses (or more) of poliovirus vaccines; 1 dose (or more) of any measles-containing vaccine; 3 doses (or more) of Haemophilus influenzae type b (Hib) vaccines; and 3 doses (or more) of hepatitis B vaccines.
fThe 4:3:1:3 series consists of 4 doses (or more) of diphtheria, tetanus toxoids and pertussis (DTP) vaccines, diphtheria and tetanus toxoids (DT), or diphtheria, tetanus toxoids and any acellular pertussis (DTaP) vaccines; 3 doses (or more) of poliovirus vaccines; 1 dose (or more) of any measles-containing vaccine; and 3 doses (or more) of Haemophilus influenzae type b (Hib) vaccines.
gThe 4:3:1 series consists of 4 doses (or more) of diphtheria, tetanus toxoids and pertussis (DTP) vaccines, diphtheria and tetanus toxoids (DT), or diphtheria, tetanus toxoids and any acellular pertussis (DTaP) vaccines, 3 doses (or more) of poliovirus vaccines; and 1 dose (or more) of any measles-containing vaccine.
hDiphtheria, tetanus toxoids, and pertussis vaccine (4 doses or more of any diphtheria, tetanus toxoids, and pertussis vaccines, including diphtheria and tetanus toxoids and any acellular pertussis vaccine).
iPoliovirus vaccine (3 doses or more).
jMeasles-mumps-rubella (MMR) vaccine (1 dose or more) was used beginning in 2005. The previous coverage years reported measles-containing vaccines .
kHaemophilus influenzae type b (Hib) vaccine (3 doses or more).
lHepatitis B vaccine (3 doses or more).
mVaricella vaccine (1 dose or more) is recommended at any visit at or after age 12 months for susceptible children (i.e., those who lack a reliable history of chickenpox).
nThe heptavalent pneumococcal conjugate vaccine (PCV) is recommended for all children ages 2–23 months and for certain children ages 24–59 months. The series consists of doses at ages 2, 4 and 6 months, and a booster dose at ages 12-15 months.
SOURCE: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases and National Center for Health Statistics, National Immunization Survey.